Početna › Mezoteliom › Ohio
Kliničke studije za Mezoteliom u državi Ohio
9 studija za Mezoteliom traži sudionike na lokacijama u državi Ohio.
Gradovi u državi Ohio
Službeni tekst studije (engleski)
SW-682 in Advanced Solid Tumors
- University Hospital of Cleveland, Cleveland
U tijeku regrutacijaFaza 1
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06251310Solid Tumor Analysis for HLA Loss of Heterozygosity (LOH) and Apheresis for CAR T- Cell Manufacturing
- The Ohio State University Comprehensive Cancer Center, Columbus
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 25. ruj 2026. · NCT04981119Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
- University Hospitals Cleveland Medical Center, Cleveland
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 16. ruj 2026. · NCT06566079Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
- Ohio State University Comprehensive Cancer Center (OSUCCC)- The James Cancer Hospital and Solove Research Institute, Columbus
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 4. kol 2026. · NCT05579366Lead-212 PSV359 Therapy for Patients With Solid Tumors
- Ohio State University, Columbus
U tijeku regrutacijaFaza 1/2
Od 18 do 90 godina · Oba spola · Ažurirano 6. srp 2026. · NCT06710756Integrated Cancer Repository for Cancer Research
- Aultman Alliance Community Hospital, Alliance
- Aultman Hospital, Canton
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 19 do 110 godina · Oba spola · Ažurirano 29. lip 2026. · NCT02012699A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression
- The Ohio State University Comprehensive Cancer Center, Columbus
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 12. lip 2026. · NCT06051695Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
- The Ohio State University Wexner Medical Center, Columbus
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Sve dobne skupine · Oba spola · Ažurirano 9. ožu 2026. · NCT04792463VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
- Taylor Cancer Research Center (site 204), Maumee
U tijeku regrutacijaFaza 1/2
Od 18 do 80 godina · Oba spola · Ažurirano 11. pro 2025. · NCT03556228Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.